Expression and clinical significance of antigen presentation components beta-2 microglobulin, HLA class I heavy chains, and HLA class II in non-small cell lung cancer (NSCLC).

被引：1
|
作者：
Datar, Ila
Villarroel-Espindola, Franz
Henick, Brian S.
Syrigos, Konstantinos N.
Toki, Maria
Rimm, David L.
Ferrone, Soldano
Herbst, Roy S.
Schalper, Kurt A.
机构：
[1] Yale Sch Med, New Haven, CT USA
[2] Natl & Kapodistrian Univ Athens, Sch Med, Athens, Greece
[3] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.12015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
12015
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Spatial Analysis and Clinical Significance of HLA Class-I and Class-II Subunit Expression in Non-Small Cell Lung Cancer
    Datar, Ila J.
    Hauc, Sacha C.
    Desai, Shruti
    Gianino, Nicole
    Henick, Brian
    Liu, Yuting
    Syrigos, Kostas
    Rimm, David L.
    Kavathas, Paula
    Ferrone, Soldano
    Schalper, Kurt A.
    CLINICAL CANCER RESEARCH, 2021, 27 (10) : 2837 - 2847
  • [2] ALTERED STRUCTURE OF HLA CLASS-I HEAVY-CHAINS ASSOCIATED WITH MOUSE BETA-2 MICROGLOBULIN
    FERRIER, P
    FONTECILLACAMPS, JC
    BUCCHINI, D
    CAILLOL, DH
    JORDAN, BR
    LEMONNIER, FA
    IMMUNOGENETICS, 1985, 21 (04) : 321 - 331
  • [3] Clinical Significance of Expression of Cancer/testis Antigen and Down-regulation of HLA Class-I in Patients with Stage I Non-small Cell Lung Cancer
    Hanagiri, Takeshi
    Shigematsu, Yoshiki
    Shinohara, Shinji
    Takenaka, Masaru
    Oka, Sohich
    Chikaishi, Yasuhiro
    Nagata, Yoshika
    Baba, Tetsuro
    Uramoto, Hidetaka
    So, Tomoko
    Yamada, Sohsuke
    ANTICANCER RESEARCH, 2013, 33 (05) : 2123 - 2128
  • [4] HLA class I antigen expression is associated with a favorable prognosis in early stage non-small cell lung cancer
    Kikuchi, Eiki
    Yamazaki, Koichi
    Torigoe, Toshihiko
    Cho, Yasushi
    Miyamoto, Masaki
    Oizumi, Satoshi
    Hommura, Fumihiro
    Dosaka-Akita, Hirotoshi
    Nishimura, Masaharu
    CANCER SCIENCE, 2007, 98 (09) : 1424 - 1430
  • [5] Clinical significance of HLA class I heavy chain expression in patients with gastric cancer
    Ueda, Yoshitake
    Ishikawa, Koichi
    Shiraishi, Norio
    Yokoyama, Shigeo
    Kitano, Seigo
    JOURNAL OF SURGICAL ONCOLOGY, 2008, 97 (05) : 451 - 455
  • [6] LOSS OF HLA CLASS-I ALLELES, HEAVY-CHAINS AND BETA-2-MICROGLOBULIN IN COLORECTAL-CANCER
    KAKLAMANIS, L
    GATTER, KC
    HILL, AB
    MORTENSEN, N
    HARRIS, AL
    KRAUSA, P
    MCMICHAEL, A
    BODMER, JG
    BODMER, WF
    INTERNATIONAL JOURNAL OF CANCER, 1992, 51 (03) : 379 - 385
  • [7] Expression of beta(2)-microglobulin-free HLA class I alpha-chains on activated T cells requires internalization of HLA class I heterodimers
    Pickl, WF
    Holter, W
    Stockl, J
    Majdic, O
    Knapp, W
    IMMUNOLOGY, 1996, 88 (01) : 104 - 109
  • [8] T-CELL INFILTRATION AND MACROPHAGE POLARIZATION CORRELATES WITH HLA CLASS I EXPRESSION IN NON-SMALL CELL LUNG CANCER
    Perea, Francisco
    Bernal, Monica
    Sanchez-Palencia, Abel
    Aptsiauri, Natalia
    Jimenez, Pilar
    Gomez-Morales, Mercedes
    Ruiz-Cabello, Francisco
    Garrido, Federico
    HLA, 2017, 89 (06) : 458 - 458
  • [9] The relationship between KRAS gene mutations and HLA class I antigen downregulation in the metastasis of non-small cell lung cancer
    He, Xiao-Peng
    Song, Fu-Jie
    Liu, Xiang-Yan
    Wang, Zhou
    Li, Xiang-Xin
    Liu, Fan-Ying
    Chen, Gang
    Jiang, Wen-Peng
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2013, 41 (05) : 1473 - 1483
  • [10] The Association of Patient HLA Class I Genotype and Genomic Alterations of Non-Small Cell Lung Cancer
    Wang, J.
    Liu, Z.
    Feng, A.
    Tian, K.
    Wei, Y.
    Wang, W.
    Pan, Q.
    Zhang, L.
    Wang, F.
    Zhang, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S542 - S542
12345